Xiao‐Ping Shi

Area of research

Physiology · Pharmacology

Research interest

Research interests include Alzheimer's disease research and treatments, Computational Drug Discovery Methods, Cholinesterase and Neurodegenerative Diseases, and Drug Transport and Resistance Mechanisms.

h-index

citations

3,465

works

NIH funding

—

primary concept

—

✉ Find email ↗

Recent publications

A case report of drug-induced liver injury after tigecycline administration: histopathological evidence and a probable causality grading as assessed by the updated RUCAM diagnostic scale

BMC Infectious Diseases 2022cited by 24position: firstdoi

Real-World Data of Tigecycline-Associated Drug-Induced Liver Injury Among Patients in China: A 3-year Retrospective Study as Assessed by the Updated RUCAM

Frontiers in Pharmacology 2021cited by 41position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Qianzhou Lv · Sun Yat-sen University2 papers (2021–2022)Donghui Lao · Sun Yat-sen University2 papers (2021–2022)Qing Xu · Sun Yat-sen University2 papers (2021–2022)Chengchun Zuo · Sun Yat-sen University1 papers (2021–2021)Xiaoyu Li · Nanchang University1 papers (2022–2022)Xiaoyu Li · Nanjing University of Chinese Medicine1 papers (2021–2021)Lingling Yu · Nanjing University of Chinese Medicine1 papers (2021–2021)

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Physiology · Pharmacology →